320 related articles for article (PubMed ID: 24448760)
1. Novel strategies for toxicological risk assessments.
Roy A; Akbarsha MA
ALTEX; 2014; 31(1):91-3. PubMed ID: 24448760
[No Abstract] [Full Text] [Related]
2. Evidence-Based Toxicology Collaboration (EBTC). Editorial.
von Aulock S
ALTEX; 2013; 30(1):1. PubMed ID: 23451363
[No Abstract] [Full Text] [Related]
3. Novel technologies and an overall strategy to allow hazard assessment and risk prediction of chemicals, cosmetics, and drugs with animal-free methods.
Leist M; Lidbury BA; Yang C; Hayden PJ; Kelm JM; Ringeissen S; Detroyer A; Meunier JR; Rathman JF; Jackson GR; Stolper G; Hasiwa N
ALTEX; 2012; 29(4):373-88. PubMed ID: 23138508
[TBL] [Abstract][Full Text] [Related]
4. Alternatives to the use of animals in safety testing as required by the EU-Cosmetics Directive 2009.
Vogel R
ALTEX; 2009; 26(3):223-6. PubMed ID: 19907908
[TBL] [Abstract][Full Text] [Related]
5. Toxicity testing: the need for new maps for the future.
Balls M
Altern Lab Anim; 2011 Oct; 39(5):417-8. PubMed ID: 22103936
[No Abstract] [Full Text] [Related]
6. The use and interpretation of in vitro data in regulatory toxicology: cosmetics, toiletries and household products.
Indans I
Toxicol Lett; 2002 Feb; 127(1-3):177-82. PubMed ID: 12052656
[TBL] [Abstract][Full Text] [Related]
7. The integrated project ReProTect: a novel approach in reproductive toxicity hazard assessment.
Hareng L; Pellizzer C; Bremer S; Schwarz M; Hartung T
Reprod Toxicol; 2005; 20(3):441-52. PubMed ID: 15899576
[TBL] [Abstract][Full Text] [Related]
8. Introduction to the EU REACH legislation.
Grindon C; Combes R
Altern Lab Anim; 2006 Mar; 34 Suppl 1():5-10. PubMed ID: 16555955
[TBL] [Abstract][Full Text] [Related]
9. Integrated Approaches to Testing and Assessment.
Casati S
Basic Clin Pharmacol Toxicol; 2018 Sep; 123 Suppl 5():51-55. PubMed ID: 29604238
[TBL] [Abstract][Full Text] [Related]
10. A critical appraisal of the process of regulatory implementation of novel in vivo and in vitro methods for chemical hazard and risk assessment.
Piersma AH; Ezendam J; Luijten M; Muller JJ; Rorije E; van der Ven LT; van Benthem J
Crit Rev Toxicol; 2014 Nov; 44(10):876-94. PubMed ID: 25058877
[TBL] [Abstract][Full Text] [Related]
11. Toxicology and stem cells: New frontiers.
Caloni F; Ferrari M; De Angelis I
ALTEX; 2014; 31(1):94. PubMed ID: 24448761
[No Abstract] [Full Text] [Related]
12. Immunotoxicity: hazard identification and risk assessment.
Luster MI; Kimber I
Hum Exp Toxicol; 1996 Dec; 15(12):947-8. PubMed ID: 8981097
[No Abstract] [Full Text] [Related]
13. Prediction of skin sensitizers using alternative methods to animal experimentation.
Johansson H; Lindstedt M
Basic Clin Pharmacol Toxicol; 2014 Jul; 115(1):110-7. PubMed ID: 24548737
[TBL] [Abstract][Full Text] [Related]
14. Toxicology is IN: in silico, in vitro, integrated testing strategy.
Caloni F; Benfenati E; Sambuy Y
ALTEX; 2016; 33(2):187-8. PubMed ID: 27032091
[No Abstract] [Full Text] [Related]
15. Reply to: Bayesian network integrated testing strategy and beyond.
Jaworska J
ALTEX; 2013; 30(3):391. PubMed ID: 23861082
[No Abstract] [Full Text] [Related]
16. Predictive toxicology today: the transition from biological knowledge to practicable models.
Benigni R
Expert Opin Drug Metab Toxicol; 2016 Sep; 12(9):989-92. PubMed ID: 27351633
[No Abstract] [Full Text] [Related]
17. Integrated testing strategies for use in the EU REACH system.
Grindon C; Combes R; Cronin MT; Roberts DW; Garrod JF
Altern Lab Anim; 2006 Aug; 34(4):407-27. PubMed ID: 16945008
[TBL] [Abstract][Full Text] [Related]
18. Applications of reconstructed skin models in pharmaco-toxicological trials.
Damour O; Augustin C; Black AF
Med Biol Eng Comput; 1998 Nov; 36(6):825-32. PubMed ID: 10367477
[TBL] [Abstract][Full Text] [Related]
19. Strategies to replace in vivo acute systemic toxicity testing. The report and recommendations of ECVAM Workshop 50.
Gennari A; van den Berghe C; Casati S; Castell J; Clemedson C; Coecke S; Colombo A; Curren R; Dal Negro G; Goldberg A; Gosmore C; Hartung T; Langezaal I; Lessigiarska I; Maas W; Mangelsdorf I; Parchment R; Prieto P; Sintes JR; Ryan M; Schmuck G; Stitzel K; Stokes W; Vericat JA; Gribaldo L;
Altern Lab Anim; 2004 Oct; 32(4):437-59. PubMed ID: 15651930
[No Abstract] [Full Text] [Related]
20. REACH testing requirements must not be driven by reproductive toxicity testing.
Spielmann H; Vogel R
Altern Lab Anim; 2006 Aug; 34(4):365-6. PubMed ID: 16945004
[No Abstract] [Full Text] [Related]
[Next] [New Search]
